CbdMD Price To Sales Ratio vs Interest Coverage Analysis
YCBD Stock | USD 0.49 0.02 3.92% |
CbdMD financial indicator trend analysis is way more than just evaluating cbdMD Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether cbdMD Inc is a good investment. Please check the relationship between CbdMD Price To Sales Ratio and its Interest Coverage accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Price To Sales Ratio vs Interest Coverage
Price To Sales Ratio vs Interest Coverage Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of cbdMD Inc Price To Sales Ratio account and Interest Coverage. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between CbdMD's Price To Sales Ratio and Interest Coverage is -0.57. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Interest Coverage in the same time period over historical financial statements of cbdMD Inc, assuming nothing else is changed. The correlation between historical values of CbdMD's Price To Sales Ratio and Interest Coverage is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of cbdMD Inc are associated (or correlated) with its Interest Coverage. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Coverage has no effect on the direction of Price To Sales Ratio i.e., CbdMD's Price To Sales Ratio and Interest Coverage go up and down completely randomly.
Correlation Coefficient | -0.57 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing cbdMD Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CbdMD sales, a figure that is much harder to manipulate than other cbdMD Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Interest Coverage
Most indicators from CbdMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into cbdMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. At present, CbdMD's Selling General Administrative is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 22.3M | 15.0M | 17.2M | 14.4M | Total Revenue | 35.4M | 24.2M | 27.8M | 22.6M |
CbdMD fundamental ratios Correlations
Click cells to compare fundamentals
CbdMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CbdMD fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 110.8M | 124.9M | 40.8M | 16.2M | 18.6M | 17.7M | |
Short Long Term Debt Total | 8.7M | 6.1M | 4.9M | 3.7M | 4.2M | 3.4M | |
Other Current Liab | 3.6M | 2.7M | 2.1M | 1.5M | 1.7M | 1.5M | |
Total Current Liabilities | 7.7M | 6.9M | 5.3M | 4.7M | 5.4M | 4.1M | |
Total Stockholder Equity | 79.2M | 103.1M | 31.4M | 9.0M | 10.4M | 9.9M | |
Property Plant And Equipment Net | 10.8M | 8.7M | 5.5M | 4.1M | 4.7M | 3.9M | |
Net Debt | (6.1M) | (20.3M) | (1.9M) | 1.9M | 1.7M | 1.8M | |
Retained Earnings | (47.4M) | (73.3M) | (147.4M) | (174.4M) | (156.9M) | (149.1M) | |
Accounts Payable | 2.9M | 3.0M | 2.0M | 1.9M | 2.2M | 1.7M | |
Cash | 14.8M | 26.4M | 6.7M | 1.8M | 2.1M | 2.0M | |
Non Current Assets Total | 87.1M | 88.4M | 24.8M | 8.1M | 9.3M | 8.9M | |
Cash And Short Term Investments | 15.1M | 27.4M | 7.7M | 1.8M | 2.1M | 2.0M | |
Net Receivables | 911.5K | 1.1M | 1.4M | 1.2M | 1.4M | 1.6M | |
Liabilities And Stockholders Equity | 110.8M | 124.9M | 40.8M | 16.2M | 18.6M | 17.7M | |
Non Current Liabilities Total | 24.0M | 14.8M | 4.1M | 2.5M | 2.9M | 2.7M | |
Inventory | 4.6M | 5.0M | 4.3M | 4.1M | 4.7M | 2.9M | |
Other Current Assets | 2.8M | 2.9M | 2.6M | 1.0M | 1.2M | 1.5M | |
Other Stockholder Equity | 126.5M | 176.4M | 178.8M | 183.4M | 210.9M | 221.4M | |
Total Liab | 31.7M | 21.7M | 9.4M | 7.2M | 8.2M | 16.2M | |
Property Plant And Equipment Gross | 10.8M | 10.6M | 6.6M | 5.7M | 6.5M | 4.5M | |
Total Current Assets | 23.7M | 36.5M | 16.0M | 8.1M | 9.3M | 14.4M | |
Accumulated Other Comprehensive Income | (2.5M) | 0.0 | (913.1K) | (5M) | (4.5M) | (4.3M) | |
Short Term Debt | 1.2M | 1.2M | 1.2M | 1.3M | 1.5M | 1.0M | |
Common Stock | 52.1K | 57.8K | 60.7K | 3.0K | 3.4K | 3.2K | |
Property Plant Equipment | 1.7M | 10.0M | 8.2M | 5.3M | 6.1M | 3.5M | |
Common Stock Shares Outstanding | 1.0M | 1.2M | 1.3M | 2.0M | 2.3M | 2.4M | |
Current Deferred Revenue | 161.5K | 7.3K | 45.1K | (1.5B) | (1.3B) | (1.3B) | |
Short Term Investments | 2.2M | 798.5K | 276.5K | 1.0M | 1M | 0.0 | |
Net Invested Capital | 80.7M | 103.2M | 31.4M | 9.0M | 10.4M | 9.9M | |
Net Working Capital | 16.0M | 29.6M | 10.7M | 3.4M | 3.9M | 3.7M | |
Other Liab | 53.0M | 17.2M | 10.0M | 398.5K | 358.6K | 340.7K | |
Net Tangible Assets | (38.7M) | 2.9M | 23.5M | 13.6M | 15.6M | 16.4M | |
Other Assets | 754.5K | 7.6M | 529.6K | 244.6K | 220.1K | 209.1K | |
Capital Stock | 52.6K | 62.8K | 65.7K | 8.0K | 9.2K | 8.7K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.90) | Revenue Per Share 7.06 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) | Return On Equity (1.35) |
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.